Skip to main content

HEALTH

  • Mylan, Biocon enter deal on generic analog insulins

    PITTSBURGH — Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

    Under the deal, Mylan will have the rights to develop and market Biocon's Glargine, Lispro and Aspart, respectively generic versions of Sanofi's Lantus, Eli Lilly's Humalog and Novo Nordisk's NovoLog.

  • Pharmavite expands Voots into Walgreens

    NORTHRIDGE, Calif. — Pharmavite on Tuesday announced that its Voots Veggie-Fruit Tarts brand, a fruit- and vegetable-based supplement for kids ages 4 years and older, are now available for purchase at Walgreens locations nationwide.

  • Reports: Insurers, employers support YMCA diabetes program

    NEW YORK — The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

  • FDA approves Aurobindo diabetes drug

    HYDERABAD, India — The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.

    Aurobindo announced the approval of pioglitazone tablets in the 15 mg, 30 mg and 45 mg strengths, in addition to the earlier tentative approval it received for pioglitazone and metformin hydrochloride tablets in the 15 mg/500 mg and 15 mg/850 mg strengths.

  • FDA, FTC crack down on distributors making unapproved cold, flu relief claims

    SILVER SPRING, Md. — The Food and Drug Administration and the Federal Trade Commission last week issued a number of warning letters to distributors of "unapproved medicines," noting that because each of the products identified claimed to prevent or treat the cold or flu, they need to be registered and approved by the FDA. And because none of the ingredients listed are in fact monographed OTC cough, cold or flu symptom relievers, those products would additionally need to be filed as "new drugs."

  • Report: C&D introduces First Response campaign targeting Hispanics

    NEW YORK — Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.

  • Study finds dramatic improvement in blood-sugar control among diabetes patients

    NEW YORK — Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

  • CDC: Flu activity drops to 3.2%, still above national baseline of 2.2%

    ATLANTA — For the week ended Feb. 9, influenza activity decreased to 3.2% — still above the baseline of 2.2%, but an indicator this year's flu season is on its way out. 

    Eleven states and New York City were still experiencing high influenza-like illness activity, while 10 states reported moderate activity.

Related Topics

X
This ad will auto-close in 10 seconds